His main research concerns Immunology, Virology, Internal medicine, Hepatitis C virus and Hepatitis B virus. The study incorporates disciplines such as Cirrhosis and Hepatitis E virus in addition to Immunology. Markus Cornberg studied Virology and T cell that intersect with Epitope.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Boceprevir, Viral load and Sofosbuvir. His work deals with themes such as Liver disease and Hepatitis C, which intersect with Hepatitis C virus. His Hepatitis B virus study incorporates themes from Viral hepatitis, Hepatitis B and Intensive care medicine.
Markus Cornberg focuses on Immunology, Internal medicine, Virology, Hepatitis C virus and Gastroenterology. Immune system, T cell, Virus, CD8 and Hepatitis B are the subjects of his Immunology studies. His work in Hepatitis B tackles topics such as Viral hepatitis which are related to areas like Hepatitis D.
His studies in Internal medicine integrate themes in fields like HBsAg and Ribavirin. His research investigates the connection between Virology and topics such as Cytotoxic T cell that intersect with problems in Epitope. As a part of the same scientific study, Markus Cornberg usually deals with the Hepatitis C virus, concentrating on Hepatitis C and frequently concerns with Liver disease.
Markus Cornberg spends much of his time researching Internal medicine, Gastroenterology, Virology, Hepatitis C and Cirrhosis. His Internal medicine research is multidisciplinary, incorporating elements of HBsAg and Hepatitis C virus. His work is dedicated to discovering how HBsAg, Hepatitis B are connected with Hepatitis B virus and Immune system and other disciplines.
His work on Virus as part of general Virology study is frequently connected to Coronavirus, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Hepatitis C study also includes fields such as
Markus Cornberg mostly deals with Internal medicine, Immunology, Hepatitis C virus, Cirrhosis and Hepatitis D. His study explores the link between Internal medicine and topics such as Gastroenterology that cross with problems in Cohort. Markus Cornberg works on Immunology which deals in particular with Immune system.
Markus Cornberg interconnects Cytotoxic T cell, Hepatitis C and Environmental health in the investigation of issues within Hepatitis C virus. His work on Spontaneous bacterial peritonitis as part of general Cirrhosis research is frequently linked to Pandemic, bridging the gap between disciplines. His Hepatitis D research also works with subjects such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Treatment of Acute Hepatitis C with Interferon Alfa-2b
Elmar Jaeckel;Markus Cornberg;Heiner Wedemeyer;Teresa Santantonio.
The New England Journal of Medicine (2001)
Treating viral hepatitis C: efficacy, side effects, and complications
M P Manns;H Wedemeyer;M Cornberg.
Gut (2006)
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen.
The Lancet Gastroenterology & Hepatology (2018)
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Markus Cornberg;Homie A. Razavi;Alfredo Alberti;Enos Bernasconi.
Liver International (2011)
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
Jerzy Jaroszewicz;Jerzy Jaroszewicz;Beatriz Calle Serrano;Karsten Wursthorn;Katja Deterding.
Journal of Hepatology (2010)
Natural killer cells act as rheostats modulating antiviral T cells
Stephen N. Waggoner;Markus Cornberg;Liisa K. Selin;Raymond M. Welsh.
Nature (2012)
Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.
Henry Lik-Yuen Chan;Alex Thompson;Michelle Martinot-Peignoux;Teerha Piratvisuth.
Journal of Hepatology (2011)
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno.
Journal of Viral Hepatitis (2014)
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.
Johannes Wiegand;Peter Buggisch;Wulf Boecher;Stefan Zeuzem.
Hepatology (2006)
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
Tobias Boettler;Philip N. Newsome;Philip N. Newsome;Mario U. Mondelli;Mojca Maticic;Mojca Maticic.
JHEP reports : innovation in hepatology (2020)
Journal of Hepatology
(Impact Factor: 30.083)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Hannover Medical School
Hannover Medical School
Goethe University Frankfurt
Goethe University Frankfurt
University of Massachusetts Medical School
Université Paris Cité
Instituto de Salud Carlos III
Hannover Medical School
University of Massachusetts Medical School
National and Kapodistrian University of Athens
Brigham Young University
Chonnam National University
University of Wisconsin–Madison
University of Naples Federico II
Sardar Patel University
Medical University of Vienna
University of Tokyo
University of Manchester
Fukushima Medical University
Handong Global University
Eburon Resources LLC
University of Colorado Denver
University of Arizona
University of Louisville
University of Pittsburgh
University of Liverpool